Induced pluripotent stem cells can effectively differentiate into multiple functional lymphocyte lineages in vivo with negligible bias

Stem Cells and Development

Volumn 25, Issue 6, 2016, Pages 462-471

  Lan, Tianshu ^a   Wang, Libin ^b,c   Xu, Lin ^a   Jin, Ning ^a   Yan, Guoliang ^a   Xia, Junjie ^a   Wang, Hailong ^a   Zhuang, Guohong ^a   Gao, Chang ^a   Meng, Luxi ^d   Du, Feifei ^a   Zhou, Qi ^b   Qi, Zhongquan ^a  

^a XIAMEN UNIVERSITY   (China)

^b INSTITUTE OF ZOOLOGY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^d THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; BODY WEIGHT; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; EMBRYONIC STEM CELL; FEMALE; FIBROBLAST; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HUMAN EMBRYONIC STEM CELL; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; INDUCED PLURIPOTENT STEM CELL; LYMPHOCYTE; LYMPHOPOIESIS; MALE;

ANIMALS; CELL LINEAGE; CELLS, CULTURED; EMBRYONIC STEM CELLS; INDUCED PLURIPOTENT STEM CELLS; LYMPHOCYTES; LYMPHOPOIESIS; MALE; MICE; MICE, INBRED C57BL;

EID: 84962560281     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2015.0248     Document Type: Article

References (53)

1. Spitzer TR, BR. Dey, YB. Chen, E. Attar, and KK. Ballen. (2012). The expanding frontier of hematopoietic cell transplantation. Cytometry B Clin Cytom 82: 271-279
2. Daley GQ. (2012). The promise, and perils of stem cell therapeutics. Cell Stem Cell 10: 740-749
3. Takahashi K, and S. Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic, and adult fibroblast cultures by defined factors. Cell 126: 663-676
4. Yu J, MA. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget, JL. Frane, S. Tian, J. Nie, GA. Jonsdottir, V. Ruotti, et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920
5. Choi KD, MA. Vodyanik, and II. Slukvin. (2009). Generation of mature human myelomonocytic cells through expansion, and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+ progenitors. J Clin Invest 119: 2818-2829
6. Themeli M, CC. Kloss, G. Ciriello, VD. Fedorov, F. Perna, M. Gonen, and M. Sadelain. (2013). Generation of tumortargeted human T lymphocytes from induced pluripotent stem cells for cancer therapy. Nat Biotechnol 31: 928-933
7. Carpenter L, R. Malladi, CT. Yang, A. French, KJ. Pilkington, RW. Forsey, J. Sloane-Stanley, KM. Silk, TJ. Davies, et al. (2011). Human induced pluripotent stem cells are capable of B-cell lymphopoiesis. Blood 117: 4008-4011
8. Iwamoto H, T. Ojima, K. Hayata, M. Katsuda, M. Miyazawa, T. Iida, M. Nakamura, M. Nakamori, M. Iwahashi, and H. Yamaue. (2014). Antitumor immune response of dendritic cells (DCs) expressing tumor-associated antigens derived from induced pluripotent stem cells: in comparison to bone marrow-derived DCs. Int J Cancer 134: 332-341
9. Knorr DA, Z. Ni, D. Hermanson, MK. Hexum, L. Bendzick, LJ. Cooper, DA. Lee, and DS. Kaufman. (2013). Clinicalscale derivation of natural killer cells from human pluripotent stem cells for cancer therapy. Stem Cells Transl Med 2: 274-283
10. Lynch MR, JC. Gasson, and H. Paz. (2011). Modified ES/OP9 co-culture protocol provides enhanced characterization of hematopoietic progeny. J Vis Exp pii: 2559
11. Kitajima K, K. Minehata, K. Sakimura, T. Nakano, and T. Hara. (2011). In vitro generation of HSC-like cells from murine ESCs/iPSCs by enforced expression of LIM-homeobox transcription factor Lhx2. Blood 117: 3748-3758
12. Wang L, L. Li, F. Shojaei, K. Levac, C. Cerdan, P. Menendez, T. Martin, A. Rouleau, and M. Bhatia. (2004). Endothelial, and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity 21: 31-41
13. Amabile G, RS. Welner, C. Nombela-Arrieta, AM. D'Alise, A. Di Ruscio, AK. Ebralidze, Y. Kraytsberg, M. Ye, O. Kocher, et al. (2013). In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. Blood 121: 1255-1264
14. Suzuki N, S. Yamazaki, T. Yamaguchi, M. Okabe, H. Masaki, S. Takaki, M. Otsu, and H. Nakauchi. (2013). Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation. Mol Ther 21: 1424-1431
15. Hanna J, M. Wernig, S. Markoulaki, CW. Sun, A. Meissner, JP. Cassady, C. Beard, T. Brambrink, LC. Wu, TM. Townes, and R. Jaenisch. (2007). Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318: 1920-1923
16. Wang L, P. Menendez, F. Shojaei, L. Li, F. Mazurier, JE. Dick, C. Cerdan, K. Levac, and M. Bhatia. (2005). Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression. J Exp Med 201: 1603-1614
17. Feng Q, SJ. Lu, I. Klimanskaya, I. Gomes, D. Kim, Y. Chung, GR. Honig, KS. Kim, and R. Lanza. (2010). Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion, and early senescence. Stem Cells 28: 704-712
18. Woods NB, AS. Parker, R. Moraghebi, MK. Lutz, AL. Firth, KJ. Brennand, WT. Berggren, A. Raya, JC. Izpisua Belmonte, FH. Gage, and IM. Verma. (2011). Brief report: efficient generation of hematopoietic precursors, and progenitors from human pluripotent stem cell lines. Stem Cells 29: 1158-1164
19. Ben-David U, and N. Benvenisty. (2011). The tumorigenicity of human embryonic, and induced pluripotent stem cells. Nat Rev Cancer 11: 268-277
20. Narsinh KH, N. Sun, V. Sanchez-Freire, AS. Lee, P. Almeida, S. Hu, T. Jan, KD. Wilson, D. Leong, et al. (2011). Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. J Clin Invest 121: 1217-1221
21. Hussein SM, NN. Batada, S. Vuoristo, RW. Ching, R. Autio, E. Narva, S. Ng, M. Sourour, R. Hamalainen, et al. (2011). Copy number variation, and selection during reprogramming to pluripotency. Nature 471: 58-62
22. Miura K, Y. Okada, T. Aoi, A. Okada, K. Takahashi, K. Okita, M. Nakagawa, M. Koyanagi, K. Tanabe, et al. (2009). Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol 27: 743-745
23. Ohi Y, H. Qin, C. Hong, L. Blouin, JM. Polo, T. Guo, Z. Qi, SL. Downey, PD. Manos, et al. (2011). Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol 13: 541-549
24. Muchkaeva IA, EB. Dashinimaev, VV. Terskikh, YV. Sukhanov, and AV. Vasiliev. (2012). Molecular mechanisms of induced pluripotency. Acta Nat 4: 12-22
25. Polo JM, S. Liu, ME. Figueroa, W. Kulalert, S. Eminli, KY. Tan, E. Apostolou, M. Stadtfeld, Y. Li, et al. (2010). Cell type of origin influences the molecular, and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 28: 848-855
26. Lee JH, JB. Lee, Z. Shapovalova, A. Fiebig-Comyn, RR. Mitchell, S. Laronde, E. Szabo, YD. Benoit, and M. Bhatia. (2014). Somatic transcriptome priming gates lineagespecific differentiation potential of human-induced pluripotent stem cell states. Nat Commun 5: 5605
27. Robinton DA, and GQ. Daley. (2012). The promise of induced pluripotent stem cells in research, and therapy. Nature 481: 295-305
28. Ganji F, S. Abroun, H. Baharvand, N. Aghdami, and M. Ebrahimi. (2015). Differentiation potential of o bombay humaninduced pluripotent stem cells, and human embryonic stem cells into fetal erythroid-like cells. Cell J 16: 426-439
29. Risueno RM, E. Sachlos, JH. Lee, JB. Lee, SH. Hong, E. Szabo, and M. Bhatia. (2012). Inability of human induced pluripotent stem cell-hematopoietic derivatives to downregulate microRNAs in vivo reveals a block in xenograft hematopoietic regeneration. Stem Cells 30: 131-139
30. Qin J, S. Sontag, Q. Lin, S. Mitzka, I. Leisten, RK. Schneider, X. Wang, A. Jauch, M. Peitz, et al. (2014). Cell fusion enhances mesendodermal differentiation of human induced pluripotent stem cells. Stem Cells Dev 23: 2875-2882
31. Araki R, M. Uda, Y. Hoki, M. Sunayama, M. Nakamura, S. Ando, M. Sugiura, H. Ideno, A. Shimada, A. Nifuji, and M. Abe. (2013). Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature 494: 100-104
32. Do JT, HW. Choi, Y. Choi, and HR. Scholer. (2011). Pluripotent hybrid cells contribute to extraembryonic as well as embryonic tissues. Stem Cells Dev 20: 1063-1069
33. Pralong D, ML. Lim, I. Vassiliev, K. Mrozik, N. Wijesundara, P. Rathjen, and PJ. Verma. (2005). Tetraploid embryonic stem cells contribute to the inner cell mass of mouse blastocysts. Cloning Stem Cells 7: 272-278
34. Zhao XY, W. Li, Z. Lv, L. Liu, M. Tong, T. Hai, J. Hao, CL. Guo, QW. Ma, et al. (2009). iPS cells produce viable mice through tetraploid complementation. Nature 461: 86-90
35. Kang L, J. Wang, Y. Zhang, Z. Kou, and S. Gao. (2009). iPS cells can support full-term development of tetraploid blastocystcomplemented embryos. Cell Stem Cell 5: 135-138
36. Nagy A, E. Gocza, EM. Diaz, VR. Prideaux, E. Ivanyi, M. Markkula, and J. Rossant. (1990). Embryonic stem cells alone are able to support fetal development in the mouse. Development 110: 815-821
37. McLaughlin KJ. (1993). Production of tetraploid embryos by electrofusion. Methods Enzymol 225: 919-930
38. Tong M, Z. Lv, L. Liu, H. Zhu, QY. Zheng, XY. Zhao, W. Li, YB. Wu, HJ. Zhang, et al. (2011). Mice generated from tetraploid complementation competent iPS cells show similar developmental features as those from ES cells but are prone to tumorigenesis. Cell Res 21: 1634-1637
39. Wang Y, J. Chen, JL. Hu, XX. Wei, D. Qin, J. Gao, L. Zhang, J. Jiang, JS. Li, et al. (2011). Reprogramming of mouse, and human somatic cells by high-performance engineered factors. EMBO Rep 12: 373-378
40. Wang L, J. Cao, Y. Wang, T. Lan, L. Liu, W. Wang, N. Jin, J. Gong, C. Zhang, et al. (2015). Immunogenicity, and functional evaluation of iPSC-derived organs for transplantation. Cell Discov 1: 15015
41. Kim K, A. Doi, B. Wen, K. Ng, R. Zhao, P. Cahan, J. Kim, MJ. Aryee, H. Ji, et al. (2010). Epigenetic memory in induced pluripotent stem cells. Nature 467: 285-290
42. Drukker M, G. Katz, A. Urbach, M. Schuldiner, G. Markel, J. Itskovitz-Eldor, B. Reubinoff, O. Mandelboim, and N. Benvenisty. (2002). Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA 99: 9864-9869
43. Suarez-Alvarez B, RM. Rodriguez, V. Calvanese, MA. Blanco-Gelaz, ST. Suhr, F. Ortega, J. Otero, JB. Cibelli, H. Moore, MF. Fraga, and C. Lopez-Larrea. (2010). Epigenetic mechanisms regulate MHC, and antigen processing molecules in human embryonic, and induced pluripotent stem cells. PLoS One 5: e10192
44. Aptsiauri N, T. Cabrera, A. Garcia-Lora, MA. Lopez-Nevot, F. Ruiz-Cabello, and F. Garrido. (2007). MHC class I antigens, and immune surveillance in transformed cells. Int Rev Cytol 256: 139-189
45. Kim EM, G. Manzar, and N. Zavazava. (2013). Human iPS cell-derived hematopoietic progenitor cells induce T-cell anergy in in vitro-generated alloreactive CD8(+) T cells. Blood 121: 5167-5175
46. Vizcardo R, K. Masuda, D. Yamada, T. Ikawa, K. Shimizu, S. Fujii, H. Koseki, and H. Kawamoto. (2013). Regeneration of human tumor antigen-specific T cells from iPSCs derived from mature CD8(+) T cells. Cell Stem Cell 12: 31-36
47. Laurent LC, I. Ulitsky, I. Slavin, H. Tran, A. Schork, R. Morey, C. Lynch, JV. Harness, S. Lee, et al. (2011). Dynamic changes in the copy number of pluripotency, and cell proliferation genes in human ESCs, and iPSCs during reprogramming, and time in culture. Cell Stem Cell 8: 106-118
48. Newman AM, and JB. Cooper. (2010). Lab-specific gene expression signatures in pluripotent stem cells. Cell Stem Cell 7: 258-262
49. Ledran MH, A. Krassowska, L. Armstrong, I. Dimmick, J. Renstrom, R. Lang, S. Yung, M. Santibanez-Coref, E. Dzierzak, et al. (2008). Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. Cell Stem Cell 3: 85-98
50. Kyba M, RC. Perlingeiro, and GQ. Daley. (2002). HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell, and yolk sac hematopoietic progenitors. Cell 109: 29-37
51. Pilat S, S. Carotta, B. Schiedlmeier, K. Kamino, A. Mairhofer, E. Will, U. Modlich, P. Steinlein, W. Ostertag, et al. (2005). HOXB4 enforces equivalent fates of ES-cell-derived, and adult hematopoietic cells. Proc Natl Acad Sci USA 102: 12101-12106
52. Schwenk F, B. Zevnik, J. Bruning, M. Rohl, A. Willuweit, A. Rode, T. Hennek, G. Kauselmann, R. Jaenisch, and R. Kuhn. (2003). Hybrid embryonic stem cell-derived tetraploid mice show apparently normal morphological, physiological, and neurological characteristics. Mol Cell Biol 23: 3982-3989
53. Cowley DE, D. Pomp, WR. Atchley, EJ. Eisen, and D. Hawkins-Brown. (1989). The impact of maternal uterine genotype on postnatal growth, and adult body size in mice. Genetics 122: 193-203